In partnership with Miami-based medical cannabis company Cansortium, the Philadelphia College of Osteopathic Medicine will launch an interdisciplinary research program on medical cannabis’ effect on the body.
A statement from the Bala Cynwyd college calls the research program “significant,” and says it will let a team of investigators examine the impact of medical marijuana on physical and mental health, quality of life, chronic pain, and opioid use and addiction.
In order to form the partnership, PCOM will re-apply to become a certified Academic Clinical Research Center under Pennsylvania’s Medical Marijuana law. Cansortium Health Partners, a subsidiary of Cansortium Holdings, will in turn apply as a Clinical Registrant.
“Pennsylvania is poised to become a national and international leader in medical cannabis research,” said PCOM president Jay Feldstein.
Cansortium, through its brand Knox Medical, earned a license to dispense medical marijuana in Pennsylvania’s York County in 2017. Knox also operates a dispensary in Hanover, Pa.
Jose Hidalgo, CEO